PD-L1 inhibitor

Advertisement

cGxPJobs Banner

Abbisko and AstraZeneca Advance Oral PD-L1 Therapy for NSCLC

SHANGHAI, China, July 1, 2026 Abbisko Therapeutics and AstraZeneca have entered into a strategic collaboration to advance the clinical...

By cGxPwire Editor
July 3, 2026

Read More

.Clinical Bio-Pharma

Glenmark Launches Phase 3 Global Study of Envafolimab for Lung Cancer

MUMBAI, India, September 5, 2025 — Glenmark Pharmaceuticals has announced the initiation of a multi-country Phase 3 clinical trial...

By cGxPwire Editor
September 11, 2025

Read More

Advertisement

cGxPJobs

Directory